Literature DB >> 16230356

tumor suppressor p53 binds with high affinity to CTG.CAG trinucleotide repeats and induces topological alterations in mismatched duplexes.

Korden Walter1, Gabriele Warnecke, Richard Bowater, Wolfgang Deppert, Ella Kim.   

Abstract

DNA binding is central to the ability of p53 to function as a tumor suppressor. In line with the remarkable functional versatility of p53, which can act on DNA as a transcription, repair, recombination, replication, and chromatin accessibility factor, the modes of p53 interaction with DNA are also versatile. One feature common to all modes of p53-DNA interaction is the extraordinary sensitivity of p53 to the topology of its target DNA. Whereas the strong impact of DNA topology has been demonstrated for p53 binding to sequence-specific sites or to DNA lesions, the possibility that DNA structure-dependent recognition may underlie p53 interaction with other types of DNA has not been addressed until now. We demonstrate for the first time that conformationally flexible CTG.CAG trinucleotide repeats comprise a novel class of p53-binding sites targeted by p53 in a DNA structure-dependent mode in vitro and in vivo. Our major finding is that p53 binds to CTG.CAG tracts by different modes depending on the conformation of DNA. Although p53 binds preferentially to hairpins formed by either CTG or CAG strands, it can also bind to linear forms of CTG.CAG tracts such as canonic B DNA or mismatched duplex. Intriguingly, by binding to a mismatched duplex p53 can induce further topological alterations in DNA, indicating that p53 may act as a DNA topology-modulating factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230356     DOI: 10.1074/jbc.M507038200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity.

Authors:  Timo Quante; Benjamin Otto; Marie Brázdová; Iva Kejnovská; Wolfgang Deppert; Genrich V Tolstonog
Journal:  Cell Cycle       Date:  2012-08-21       Impact factor: 4.534

2.  Functional analysis of p53 binding under differential stresses.

Authors:  Adam J Krieg; Ester M Hammond; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

3.  Wild-type p53 binds to MYC promoter G-quadruplex.

Authors:  Marek Petr; Robert Helma; Alena Polášková; Aneta Krejčí; Zuzana Dvořáková; Iva Kejnovská; Lucie Navrátilová; Matej Adámik; Michaela Vorlíčková; Marie Brázdová
Journal:  Biosci Rep       Date:  2016-10-14       Impact factor: 3.840

4.  p53 Specifically Binds Triplex DNA In Vitro and in Cells.

Authors:  Marie Brázdová; Vlastimil Tichý; Robert Helma; Pavla Bažantová; Alena Polášková; Aneta Krejčí; Marek Petr; Lucie Navrátilová; Olga Tichá; Karel Nejedlý; Martin L Bennink; Vinod Subramaniam; Zuzana Bábková; Tomáš Martínek; Matej Lexa; Matej Adámik
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 5.  Recognition of Local DNA Structures by p53 Protein.

Authors:  Václav Brázda; Jan Coufal
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

6.  Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Authors:  Marie Brázdová; Lucie Navrátilová; Vlastimil Tichý; Kateřina Němcová; Matej Lexa; Roman Hrstka; Petr Pečinka; Matej Adámik; Borivoj Vojtesek; Emil Paleček; Wolfgang Deppert; Miroslav Fojta
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

Review 7.  The Rich World of p53 DNA Binding Targets: The Role of DNA Structure.

Authors:  Václav Brázda; Miroslav Fojta
Journal:  Int J Mol Sci       Date:  2019-11-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.